Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Interleukin 15 Receptor alpha
Most Correlated Studies
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
- L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
Most Relevant Literature
- Screening of small molecule inhibitors of IL-15Rα using molecular docking and surface plasmon resona…
- A Chimeric IL-15/IL-15Rα Molecule Expressed on NFκB-Activated Dendritic Cells Supports Their Capabil…
- RUNX2 and IL-15RA Polymorphisms associated with OPLL in the Han and Mongolian population.
- IL-15 and IL15RA in Osteoarthritis: Association With Symptoms and Protease Production, but Not Struc…
- Interleukin-15 directly stimulates pro-oxidative gene expression in skeletal muscle in-vitro via a m…
Most Relevant Clinical Trials
- Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungo…
- Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cel…
- BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage
- Effect of NB-UVB on the Tissue Level of IL 15 and IL-15Rα in Active Non Segmental Vitiligo Cases.
- Preemptive Therapy of GVHD
